Farther Finance Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Farther Finance Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$209.01 - $232.56 $66,047 - $73,488	316 Added 94.61%	650 $141 Million
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $7,709 - $8,864	39 Added 5.74%	719 $163 Million
Q3 2023 Nov 13, 2023	BUY	$201.05 - $221.7 $69,563 - $76,708	346 Added 103.59%	680 $137 Million
Q2 2023 May 13, 2024	BUY	$211.93 - $241.33 $16,954 - $19,306	80 Added 31.5%	334 $80.6 Million
Q2 2023 Sep 12, 2023	BUY	$211.93 - $241.33 $16,954 - $19,306	80 Added 31.5%	334 $80.6 Million
Q1 2023 May 13, 2024	SELL	$213.32 - $257.83 $99,193 - $119,890	-465 Reduced 64.67%	254 $58.3 Million
Q1 2023 Sep 12, 2023	BUY	$213.32 - $257.83 $639 - $773	3 Added 1.2%	254 $58.3 Million
Q4 2022 Sep 11, 2023	BUY	$203.72 - $248.97 $51,133 - $62,491	251 New	251 $59.1 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Farther Finance Advisors, LLC with notifications on news.